| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2014 | WO2014024013A1 Pseudouridimycin (pum) and its derivates |
| 02/13/2014 | WO2014023934A1 Immunomodulatory compounds |
| 02/13/2014 | WO2014023867A2 Empty liposomes as adjuvant for various active principles, administered independently in the conventional galenic form thereof |
| 02/13/2014 | WO2014023815A1 New antibacterial compounds |
| 02/13/2014 | WO2014023814A1 New antibacterial compounds |
| 02/13/2014 | WO2014023813A1 Alkylpyrimidine derivatives for the treatment of viral infections and further diseases |
| 02/13/2014 | WO2014023791A1 Treatment of drug resistance in hormone-sensitive cancer |
| 02/13/2014 | WO2014023754A1 Compounds for use in the treatment of disorders that are ameliorated by inhibition of hdac |
| 02/13/2014 | WO2014023732A1 Niclosamide and its derivatives for use in the treatment of solid tumors |
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides |
| 02/13/2014 | WO2014023710A1 UNCOATED TABLET COMPRISING GRANULES INCLUDING A β-LACTAM ANTIBIOTIC AND HIGHLY DISPERSED SILICONE DIOXIDE |
| 02/13/2014 | WO2014023708A1 Substituted hetero-azepinones |
| 02/13/2014 | WO2014023698A1 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof |
| 02/13/2014 | WO2014023691A1 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 02/13/2014 | WO2014023682A1 Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof |
| 02/13/2014 | WO2014023681A1 A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside |
| 02/13/2014 | WO2014023652A1 Pharmaceutical formulation comprising tapentadol and cyclodextrin |
| 02/13/2014 | WO2014023643A1 Multitarget faah and cox inhibitors and therapeutical uses thereof |
| 02/13/2014 | WO2014023390A2 (aza-)isoquinolinone derivatives |
| 02/13/2014 | WO2014023385A1 Pyridopyrimidine derivatives as protein kinase inhibitors |
| 02/13/2014 | WO2014023367A1 Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor ror gamma |
| 02/13/2014 | WO2014023329A1 Niclosamide and its derivatives for use in the treatment of solid tumors |
| 02/13/2014 | WO2014023325A1 Multitarget faah and cox inhibitors and therapeutical uses thereof |
| 02/13/2014 | WO2014023288A1 Method for introducing biologically active substances into the brain |
| 02/13/2014 | WO2014023272A1 Hyaluronic acid derivative, method of preparation thereof, method of modification thereof and use thereof |
| 02/13/2014 | WO2014023271A1 Casein kinase 1 inhibitors for the treatment of b-cell chronic lymphocytic|leukemia |
| 02/13/2014 | WO2014023270A1 Salts or co-crystals of ethyl n-[2-amino-4-[(4-fluorophenyl)methylamino]-phenyl]carbamate |
| 02/13/2014 | WO2014023258A1 Pyrazole carboxamide compounds, compositions and methods of use |
| 02/13/2014 | WO2014023191A1 N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof |
| 02/13/2014 | WO2014023104A1 Compound with xanthine oxidase inhibitory activity and salt thereof, preparation method and usage for the same |
| 02/13/2014 | WO2014023083A1 PI3Kδ INHIBITOR |
| 02/13/2014 | WO2014023082A1 Composition used for improving macular pigment density in eyes and preventing or treating age-related macular degeneration |
| 02/13/2014 | WO2014023081A1 Artemisinin derivatives, preparation process and use thereof |
| 02/13/2014 | WO2014023063A1 High efficiency telomerase inhibitor and application of same in antitumor drug |
| 02/13/2014 | WO2014023027A1 Erlotinib hydrochloride polymorph and preparation method therefor |
| 02/13/2014 | WO2014022936A1 Chlamydia antigen compositions and uses thereof |
| 02/13/2014 | WO2014022923A1 Antibacterial inhibitors |
| 02/13/2014 | WO2014022886A1 A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient |
| 02/13/2014 | WO2014022879A1 Compounds for the treatment of mtor pathway related diseases |
| 02/13/2014 | WO2013192517A3 Compounds for treating infectious diseases |
| 02/13/2014 | WO2013192049A3 1,2,4-triazine-6-carboxamide kinase inhibitors |
| 02/13/2014 | WO2013190569A3 Novel salts of sunitinib and preparation thereof |
| 02/13/2014 | WO2013188767A8 Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin |
| 02/13/2014 | WO2013188750A3 Substituted macrocyclic compounds having proteasome inhibitory activity |
| 02/13/2014 | WO2013188273A8 Topical ophthalmological pharmaceutical composition containing axitinib |
| 02/13/2014 | WO2013188268A8 Topical ophthalmological pharmaceutical composition containing pazopanib |
| 02/13/2014 | WO2013177170A3 Methods for drug screen using zebrafish model and the compounds screened thereform |
| 02/13/2014 | WO2013169939A3 New methods |
| 02/13/2014 | WO2013102195A8 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 02/13/2014 | US20140047572 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury |
| 02/13/2014 | US20140047569 Methods of Treating Disorders Associated with Protein Aggregation |
| 02/13/2014 | US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/13/2014 | US20140046276 Wound care product |
| 02/13/2014 | US20140046275 Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions |
| 02/13/2014 | US20140046274 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith |
| 02/13/2014 | US20140046242 Delivery of corticosteroids through iontophoresis |
| 02/13/2014 | US20140046063 Treatment of service persistant asthma with masitinib |
| 02/13/2014 | US20140046055 Compounds and methods for inhibiting mitotic progression |
| 02/13/2014 | US20140046052 Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients |
| 02/13/2014 | US20140046046 Glucopyranosyl-substituted phenyl derivates, medicaments containing such compounds, their use and process for their manufacture |
| 02/13/2014 | US20140045950 Drug delivery vehicle |
| 02/13/2014 | US20140045948 Kit of ophthalmic composition |
| 02/13/2014 | US20140045947 Methods for Maintaining or Improving Health, Well-Being and/or a Physiological Function in a Subject |
| 02/13/2014 | US20140045946 Compositions and Methods for Treatment of Glaucoma |
| 02/13/2014 | US20140045942 Topical composition |
| 02/13/2014 | US20140045941 Plant derived seed extract rich in essentially fatty acids derived from salvia hispanica l. seed: composition of matter, manufacturing process and use |
| 02/13/2014 | US20140045940 Oil body extraction and uses |
| 02/13/2014 | US20140045939 Ophthalmic compositions and methods for treating eyes |
| 02/13/2014 | US20140045937 Methods of treating polycystic ovarian syndrome using chlorogenic acid |
| 02/13/2014 | US20140045935 Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol |
| 02/13/2014 | US20140045934 Treatment of Obesity Using Non-Daily Administration of 6-O-(4-Dimethylaminoethoxy) Cinnamoyl Fumagillol |
| 02/13/2014 | US20140045932 Flavanol and carotenoid compositions |
| 02/13/2014 | US20140045929 Chroman-derived anti-androgens for treatment of androgen mediated disorders |
| 02/13/2014 | US20140045928 Polyphenol/theanine compositions |
| 02/13/2014 | US20140045927 Preparations of taxanes for intravenous administration and the preparation method thereof |
| 02/13/2014 | US20140045916 Splice-region antisense composition and method |
| 02/13/2014 | US20140045913 Lipid nano particles comprising combination of cationic lipid |
| 02/13/2014 | US20140045912 Composition and method for treatment of diabetes |
| 02/13/2014 | US20140045909 Denibulin di-hydrochloride |
| 02/13/2014 | US20140045908 Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers |
| 02/13/2014 | US20140045907 Use of Inhibitors of the Renin-Angiotensin System |
| 02/13/2014 | US20140045906 Neprilysin inhibitors |
| 02/13/2014 | US20140045904 Niacin formulations and methods with reduced flushing side effect |
| 02/13/2014 | US20140045900 Administration regime for nitrocatechols |
| 02/13/2014 | US20140045898 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy |
| 02/13/2014 | US20140045897 Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles |
| 02/13/2014 | US20140045896 1,4-dihydropyridine-3,5-dicarboxylate Derivatives And Preparation And Use Thereof |
| 02/13/2014 | US20140045895 Pharmaceutical depot for 5-fluoro-2-[[(1s)-1-(5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 02/13/2014 | US20140045894 Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug |
| 02/13/2014 | US20140045893 Methods for the administration of iloperidone |
| 02/13/2014 | US20140045891 Nitroxides for use in treating or preventing diabetes and obesity |
| 02/13/2014 | US20140045889 Combination Drug Containing Probucol and a Tetrazolyalkoxy-Dihydrocarbostyril Derivative With Superoxide Supressant Effects |
| 02/13/2014 | US20140045887 Laquinimod for treatment of cannabinoid receptor type 1(cb1) mediated disorders |
| 02/13/2014 | US20140045886 Laquinimod for treatment of gaba mediated disorders |
| 02/13/2014 | US20140045885 Decoquinate, 4-hydroxyquinolones and napthoquinones combined with levamisole, Imidazothiazole, for the prevention and treatment of sarcocystosis and equine protozoal myeloencephalitis caused by Sarcocystis and Neospora and other apicomplexan protozoans. |
| 02/13/2014 | US20140045884 Treatment methods of cognitive, emotional and mental ailments and disorders |
| 02/13/2014 | US20140045883 Ack1 kinase inhibition to treat triple negative breast cancer |
| 02/13/2014 | US20140045880 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 02/13/2014 | US20140045878 Matrix for sustained, invariant and independent release of active compounds |
| 02/13/2014 | US20140045877 Pharmaceutical preparation containing oxycodone and naloxone |